ASD ETF Price & Analysis

The Defiance Autism Impact ETF (ASD) is a sector-focused, impact-oriented exchange-traded fund that gives investors targeted exposure to companies across developed markets that provide products, services and technologies supporting individuals on the autism spectrum and the broader neurodiverse community. Classified in the Health Care sector with a broad-based niche focus, ASD assembles a diversified mix of firms involved in clinical care, diagnostics and therapeutics, assistive and adaptive technologies, behavioral and educational services, telehealth and digital health platforms, and related life-science research and support services. ASD tracks an equal-weighted index of qualifying companies from developed markets, meaning each holding is sized equally within the portfolio and the lineup is periodically rebalanced to maintain that balance. The equal-weighted approach reduces concentration in the largest names and gives relatively greater exposure to smaller and mid-sized firms that are actively developing treatments, therapies, diagnostics or inclusive services for neurodiverse populations. Constituents span healthcare subsectors and adjacent industries, offering a focused but broad-based exposure within the health-care theme. Beyond financial exposure, ASD incorporates an impact element: a portion of the fund’s profits is donated to vetted organizations dedicated to autism care, research, advocacy and improving access to resources. This makes the ETF a potential option for investors seeking to align capital appreciation with philanthropy and social impact in the neurodiversity space. ASD may suit investors looking for thematic health-care exposure centered on autism-related products and services and for those drawn to impact investing. As a sector-focused fund, it carries the typical concentration and sector-specific risks of health-care investing and may be more volatile than broadly diversified equity funds.